A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2004
11/25/2004	US20040235777 Enhancing immune response to cancer antigen comprising by administering a CpG (cytosine-phosphate diester-guanine) oligonucleotide; thrombopoiesis, anemia
11/25/2004	US20040235770 Topically administered to treat cancer and infections
11/25/2004	US20040235746 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
11/25/2004	US20040235741 Human papilloma virus treatment
11/25/2004	US20040235732 Method for modulating angiogenesis using prokineticin receptor antagonists
11/25/2004	US20040235175 Method for transfection of rna using electrical pulses
11/25/2004	US20040235172 Antigen transduced t cells used as a delivery system for antigens
11/25/2004	US20040235156 Therapeutic mixture comprising interferons and chimeric immunoglobulins for use in activation of immune response and treatment, diagnosis and prevention of cancer; immunotherapy; tissue targeted therapy
11/25/2004	US20040235135 Preparing viral nucleotide sequences where immune response-inducing antigen sequences are repositioned in the position closest to the 3' end and viral replication limiting factor gene is repositioned away from 3' promoter; for use in generating vaccine to treat and prevent viral infectious diseases
11/25/2004	US20040235134 Newcastle disease virus infectious clones, vaccines and new diagnostic assays
11/25/2004	US20040235133 Large scale production of packaged alphavirus replicons
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235118 Portions of soluble recombinant botulinum toxins
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235108 Immunoglobulin which competitively binds tetrameric form of the alpha-folate receptor for use in treatment and prevention of cell proliferfative disorders; immunotherapy
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040235083 Screening method
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040235011 Production of multimeric proteins
11/25/2004	US20040235006 Chemical compounds
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234953 Viral nucleotide sequences coding envelope proteins for use in preparing antibodies for prevention and treatment of autoimmune disorders
11/25/2004	US20040234951 Chimeric chains that coding for proteins that induce effects directed against viruses
11/25/2004	US20040234950 Method for virus propagation
11/25/2004	US20040234949 Infectious bursal disease virus capsid/envelope protein for use in developing vaccine for prevention and treatment of viral infection of chickens; veterinary medicine; immunotherapy
11/25/2004	US20040234634 Pharmaceutical compositions having appetite suppressant activity
11/25/2004	US20040234614 Chitin microparticles and their medical uses
11/25/2004	US20040234554 Hepatitis B virus crosslinked with immunogens, epitopes; capsid peptide binding to core protein; vaccine
11/25/2004	US20040234553 Cold-adapted equine influenza viruses
11/25/2004	US20040234552 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine
11/25/2004	US20040234550 Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
11/25/2004	US20040234548 treating an allergy in a subject susceptible to an anaphylactic allergic response to an allergen by administering a composition with microorganisms that produce the allergen at an effective and non-toxic dose; compositions with the microorganisms
11/25/2004	US20040234543 Hepatitis virus
11/25/2004	US20040234542 Immunoassay; open reading frame protein; detecting antibodies
11/25/2004	US20040234541 Diagnosis, therapy cancer; human leukocyte antigen
11/25/2004	US20040234539 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
11/25/2004	US20040234538 Genetic engineered polypeptide; induce immunology response
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234535 novel live vaccines for control of F. columnare in channel catfish comprising one or more rifampicin resistant mutants of F. columnare, created by multiple passaging of the native isolate on increasing concentrations of rifampicin
11/25/2004	US20040234534 Genetic engineered mutant against Escherichia; veterinary medicine
11/25/2004	US20040234533 Antigenic compositions
11/25/2004	US20040234531 Autoimmune disease; antidiabetic agents; protein
11/25/2004	US20040234530 Plasmid-specific polypeptide found in Eschericha; diagnosis of infections; induction of immunology response
11/25/2004	US20040234529 Helicobacter pylori adhesin binding group antigen
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234526 Use of a compound antagonist of esm-1 protein for producing a medicine for treating cancer
11/25/2004	US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004	US20040234523 Antiischemic agents; synergistic mixture of interleukin inhibitor and tumor necrosis factor antagonist
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234521 Antigen detection segments; crosslinking receptors
11/25/2004	US20040234520 Uses for Eph receptor antagonists and agonists
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	US20040234512 Method for treating thrombopoiesis and anemia; cytosine phosphate diester guanine; controlling remodeling of immunology system
11/25/2004	US20040234511 Genetic engineering white blood cells in vitro; gene expression of antigen; insertion into mammals
11/25/2004	US20040234506 Recombinant RSV virus expression systems and vaccines
11/25/2004	US20040234503 Materials and methods relating to improved vaccinations strategies
11/25/2004	US20040234455 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression
11/25/2004	CA2525899A1 Ovr110 antibody compositions and methods of use
11/25/2004	CA2525766A1 Method for selecting and producing vaccine components and vaccines based thereon
11/25/2004	CA2525641A1 Materials and methods for immunizing against fiv infection
11/25/2004	CA2525385A1 Grp94-based compositions and methods of use thereof
11/25/2004	CA2525370A1 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	CA2524883A1 Potassium-chloride cotransporter kcc2 modulation for treatment of pain
11/25/2004	CA2523943A1 Compositions and methods for wt1 specific immunotherapy
11/25/2004	CA2523001A1 Therapeutic use of anti-cs1 antibodies
11/25/2004	CA2522614A1 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry
11/24/2004	EP1479774A1 Viruses dependent on inducing agents for viral entry into a host cell
11/24/2004	EP1479773A1 Mite galectin
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479764A1 Heparanase-derived peptides for vaccination of tumor patients
11/24/2004	EP1479761A1 New enterovirus, vaccines, medicaments and diagnostic kits
11/24/2004	EP1479696A1 Human monoclonal antibody binding Ep-CAM, and its use in cancer therapy
11/24/2004	EP1479694A2 Intrabodies ScFv with defined framework that is stable in a reducing environment
11/24/2004	EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/24/2004	EP1479396A1 Drugs ameliorating circadian rhythum disorder
11/24/2004	EP1479390A1 Pharmaceutical preparation containing selenite
11/24/2004	EP1478927A2 Macromolecular conjugates and processes for preparing same
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478764A2 Humanized collagen antibodies and related methods
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478758A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
11/24/2004	EP1478756A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478740A2 Heteromultimeric tnf ligand family members
11/24/2004	EP1478738A1 Anti-ccr5 antibody
11/24/2004	EP1478735A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/24/2004	EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004	EP1478664A1 Tissue specific expression
11/24/2004	EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
11/24/2004	EP1478661A2 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
11/24/2004	EP1478657A2 Sequence analysis of the tetravalent rotavirus vaccine
11/24/2004	EP1478654A2 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
11/24/2004	EP1478405A2 Beta-homolysine conjugates and their use as transport enhancer

1 ... 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 ... 1823